Stieproxal

Med-Verified

ciclopirox olamine and salicylic acid, topical

Quick Summary (TL;DR)

Stieproxal is commonly used for Ciclopirox olamine and salicylic acid topical combination is specifically indicated for the management and treatment of seborrheic dermatitis,....

What it's for (Indications)

  • Ciclopirox olamine and salicylic acid topical combination is specifically indicated for the management and treatment of seborrheic dermatitis, particularly affecting the scalp.
  • This chronic inflammatory skin condition is characterized by erythema, pruritus, and greasy or dry scaling, often associated with the overgrowth of Malassezia yeasts.
  • The dual-action formulation aims to alleviate these symptoms by targeting both the fungal component and the excessive scaling.
  • It is used to reduce the characteristic scaling, itching, inflammation, and discomfort associated with seborrheic dermatitis, promoting a healthier scalp environment and improving patient quality of life.
  • This medication is strictly for external, topical application as directed by a healthcare professional.

Dosage Information

Type Guideline
Standard For the treatment of seborrheic dermatitis, the typical dosage involves applying the topical solution or shampoo formulation to affected areas of the scalp. Patients are usually instructed to wet the hair and scalp thoroughly, apply a sufficient amount of the product (e.g., 5 mL to 10 mL depending on hair length), and gently massage it into the scalp to produce a rich lather. The product should be left on the scalp for approximately 3 to 5 minutes to allow for adequate contact time before being thoroughly rinsed with water. This process is generally performed two to three times per week, or as prescribed by a physician, for a period ranging from two to four weeks. The exact duration and frequency of treatment should be determined by a healthcare provider based on the severity of the condition and the patient's response to therapy. Consistent application as directed is crucial for optimal therapeutic outcomes.

Safety & Warnings

Common Side Effects

  • Commonly reported side effects associated with the topical application of ciclopirox olamine and salicylic acid include local skin reactions at the application site.
  • These may manifest as mild to moderate irritation, burning, stinging, erythema (redness), pruritus (itching), or dryness.
  • Some individuals might experience folliculitis or changes in hair texture.
  • In rare instances, hair discoloration, particularly in patients with light-colored, grey, or chemically-treated hair, has been observed.
  • Allergic contact dermatitis, though infrequent, can occur and may present as worsening rash or severe itching.
  • Systemic absorption of either active ingredient is generally low with proper topical use; however, excessive application over large surface areas or on compromised skin could potentially lead to systemic effects.
  • Patients should report any persistent or worsening adverse reactions to their healthcare provider.

Serious Warnings

  • Black Box Warning: **Serious Warnings Regarding Systemic Salicylate Toxicity and Hypersensitivity Reactions** This product, containing salicylic acid, carries a risk of systemic salicylate toxicity (salicylism) if absorbed excessively. This risk is particularly elevated with prolonged use, application to large body surface areas, use under occlusive dressings, or application to compromised skin (e.g., severely inflamed, broken, or extensively damaged skin). Young children and infants are especially vulnerable due to their increased skin permeability and reduced metabolic capacity for salicylates, making this product contraindicated in this population. Manifestations of salicylism may include tinnitus, dizziness, nausea, vomiting, lethargy, confusion, hyperpnea, and metabolic acidosis. Patients should be carefully instructed on proper application to minimize systemic exposure and report any signs of toxicity immediately. Furthermore, severe hypersensitivity reactions, including allergic contact dermatitis, can occur. Patients experiencing signs of severe irritation, sensitization, or an allergic response (e.g., extensive rash, swelling, difficulty breathing) should immediately discontinue use and seek medical attention.
  • This medication is intended for external use only and should not be ingested or applied to eyes, mouth, or other mucous membranes.
  • Accidental contact with eyes or mucous membranes should be immediately followed by thorough rinsing with water.
  • Patients with known hypersensitivity to ciclopirox olamine, salicylic acid, or any excipients in the formulation should exercise caution, and therapy should be discontinued if signs of sensitization or severe irritation develop.
  • Care should be taken when applying the product to areas of skin with pre-existing cuts, abrasions, or extensive inflammation, as enhanced systemic absorption could occur.
  • The safety and efficacy of this combination product in pregnant or breastfeeding women have not been definitively established, and it should be used only if the potential benefits outweigh the potential risks, under the guidance of a healthcare professional.
  • Avoid using occlusive dressings, as this can increase systemic absorption of salicylic acid.
How it Works (Mechanism of Action)
The therapeutic efficacy of this combination product stems from the distinct yet complementary mechanisms of action of its active ingredients. **Ciclopirox olamine** is a broad-spectrum antifungal agent that primarily acts by inhibiting the transport of essential substances, such as amino acids and phosphate ions, into fungal cells, thereby disrupting fungal cellular metabolism and integrity. It also chelates polyvalent metal ions, inhibiting key enzymes like catalase and cytochrome P450, leading to the accumulation of toxic reactive oxygen species and subsequent cell death. Furthermore, ciclopirox possesses anti-inflammatory properties, contributing to the reduction of scalp inflammation. **Salicylic acid** functions as a potent keratolytic agent. It works by dissolving the intercellular cement substances that bind keratinocytes in the stratum corneum, leading to desquamation (shedding) of scales and hyperkeratotic tissue. This keratolytic action helps to remove existing scales, relieve pruritus, and allows for better penetration of ciclopirox into the affected skin layers. The synergistic effect addresses both the fungal overgrowth and the excessive scaling characteristic of seborrheic dermatitis.

Commercial Brands (Alternatives)

No other brands found for this formula.

AI Safety Note

Found an error? Helping us helps everyone: